Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

Carisma Therapeutics Announces A $53m Series A Financing To Develop Novel Car Macrophage

by prnewswire.com posted 1month ago 15 views
PHILADELPHIA, June 27, 2018 /PRNewswire/ -- Carisma Therapeutics Inc., formerly CARMA Therapeutics, a privately-held biotechnology company focused on the development of macrophage-based immunotherapeutics, today announced the close of a $53 million Series A financing to further expand its...